Crossmark

Prognostic significance of high serum p53 antibody titers in patients with esophageal squamous cell carcinoma

Crossref DOI link: https://doi.org/10.1007/s10388-018-0629-5

Published Online: 2018-06-29

Published Print: 2018-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Suzuki, Takashi

Yajima, Satoshi

Ishioka, Nobuki

Nanami, Tatsuki

Oshima, Yoko

Washizawa, Naohiro

Funahashi, Kimihiko

Otsuka, Seiko

Nemoto, Tetsuo

Shimada, Hideaki https://orcid.org/0000-0002-1990-8217
Funding

Funding for this research was provided by:

JSPS KAKENHI (JP16K10520)
License Information

Text and Data Mining valid from 2018-06-29
More Information

Article History

Received: 4 March 2018

Accepted: 20 June 2018

First Online: 29 June 2018

Compliance with ethical standards

:

: This retrospective study was approved by the Institutional Review Board of Toho University (Tokyo, Japan; IRB #26-256). We obtained informed consent from all participants.

: Hideaki Shimada received research fund from Medical and Biological Laboratories. Co. ltd. The other authors have no conflict of interest to declare.